Axovant Sciences Announces Presentation Time Change at Oppenheimer Healthcare Conference


BASEL, Switzerland, March 20, 2017 /PRNewswire/ -- Axovant Sciences (NYSE: AXON), a leading clinical-stage biopharmaceutical company focused on the treatment of dementia, today announced a change to the company's presentation time at the Oppenheimer 27th Annual Healthcare Conference.

Axovant will now present at 9:10 a.m. on Wednesday, March 22. A simultaneous webcast will be available for the conference in the Investors section of Axovant's website at A replay will be available for 30 days following the conference.

About Axovant Sciences

Axovant Sciences is a leading clinical-stage biopharmaceutical company focused on acquiring, developing and commercializing novel therapeutics for the treatment of dementia. Axovant intends to develop a pipeline of product candidates to comprehensively address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. Our vision is to become the leading company focused on the treatment of dementia by addressing all forms and aspects of this condition.

To view the original version on PR Newswire, visit:

SOURCE Axovant Sciences

Jonathan Neely
Head, Investor Relations and Corporate Communications
Axovant Sciences, Inc.
(212) 634-9744